WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5901 Infant (under 12 months) mortality rate: 602
GDP / capita (US$): 1'4531 Child (under 5 years) mortality rate: 932

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 1'816  1'771  1'726  1'681  1'638  1'243  1'012  801 
Births 66  66  65  64  63  52  47  40 
Surviving infants 62  61  60  59  58  46  41  34 
Pop. less than 5 years 291  285  280  275  270  213  187  147 
Pop. less than 15 years 756  738  722  706  690  561  467  348 
Female 15-49 years 448  437  425  413  401  288  231  189 

Number of reported cases

(Click for retrospective incidence data for Guinea-Bissau)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  153  259  1'332 
Mumps
ChartChart
 
Pertussis
ChartChart
  1'512  1'250 
Polio*
ChartChart
 
Rubella
ChartChart
  23 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  45 
Tetanus (total)**
ChartChart
  45  221 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea-Bissau)
Vaccine year result method % card seen                                                
BCG 2012  94  MICS   83  83  97  94  95  95  90 
DTP1 2012  94  MICS   83  84  90  92  99*  90 
DTP3 2012  83  MICS   83  68  90  83  96  90  61 
DTP4         
IPV1          73 
HepB_BD         
HepB3 2012  83  MICS   83  68  90  83  96  90 
Hib3 2012  83  MICS   83  68  90  83  96  90 
JapEnc         
MCV1          71  90  81  89  90  53 
MCV2         
MenA         
PCV1          82  50 
PCV2          74  50 
PCV3          67  50 
Pol3 2012  77  MICS   83  69  90  83  96  90  60 
Rota1          74 
RotaC          61 
RCV1         
TT2plus 2009  58  MICS   83  39  83  70  38  45  31 
PAB         
VAD1         
YFV 2012  75  MICS   83  64  90  75  73  90 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea-Bissau)
BCG
ChartChart
  94  94  94  94  94  77  90 
DTP1
ChartChart
  95  95  95  95  95  73  82 
DTP3
ChartChart
  87  87  87  87  87  49  61 
HepB3
ChartChart
  87  87  87  87  87 
HepB_BD
ChartChart
 
Hib3
ChartChart
  87  87  87  87  87 
IPV1
  30 
MCV1
ChartChart
  81  81  81  81  81  71  53 
MCV2
ChartChart
 
PCV3
ChartChart
  80  10 
Pol3
ChartChart
  87  87  87  87  87  52  60 
RCV1
 
RotaC
ChartChart
  61 
YFV
ChartChart
  75  75  53  75  75 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 11  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 9
From 80 to 89% 18
From 50 to 79% 73
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6,10,14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes    Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2017  2013-2017    2013-2017  2013 - 2017  2010-2014  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number     11  11    11 

System performance

Total Nº districts in country number 11  11  11  11  11  11  11 
Nº districts with DTP3 coverage >=80% number 10  10  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 27  45  45  91  91  64  91 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 55  27  27 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 40           

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.